Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab.
| Author | :
|
|---|---|
| Year of Publication | :
2018
|
| Journal | :
Cancer biology & therapy
|
| Number of Pages | :
0
|
| Date Published | :
2018
|
| ISSN Number | :
1538-4047
|
| DOI | :
10.1080/15384047.2017.1416938
|
| Short Title | :
Cancer Biol Ther
|
| Download citation |